Climb Bio, Inc. (CLYM)
9.91
+0.34
(+3.55%)
USD |
NASDAQ |
Oct 28, 13:44
Climb Bio Price : 9.91 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 9.09 | 10.15 | 8.815 | 9.57 | 3.904M |
| Oct 26, 2026 | 9.88 | 9.99 | 8.70 | 8.81 | 3.381M |
| Oct 23, 2026 | 10.47 | 10.66 | 10.05 | 10.19 | 495694.0 |
| Oct 22, 2026 | 10.57 | 11.23 | 10.44 | 10.54 | 654057.0 |
| Oct 21, 2026 | 10.83 | 11.26 | 10.60 | 10.87 | 930386.0 |
| Oct 20, 2026 | 9.84 | 10.99 | 9.84 | 10.80 | 1.369M |
| Oct 19, 2026 | 9.92 | 10.43 | 9.61 | 9.73 | 1.214M |
| Oct 16, 2026 | 10.89 | 10.91 | 9.690 | 9.82 | 990428.0 |
| Oct 15, 2026 | 10.32 | 10.98 | 10.25 | 10.91 | 515488.0 |
| Oct 14, 2026 | 10.19 | 10.64 | 10.09 | 10.29 | 987717.0 |
| Oct 13, 2026 | 10.75 | 10.79 | 10.18 | 10.31 | 901344.0 |
| Oct 12, 2026 | 10.91 | 11.15 | 10.72 | 10.83 | 911847.0 |
| Oct 09, 2026 | 10.81 | 11.30 | 10.75 | 11.00 | 638139.0 |
| Oct 08, 2026 | 10.55 | 11.00 | 10.27 | 10.86 | 1.149M |
| Oct 07, 2026 | 10.43 | 10.94 | 10.34 | 10.71 | 755808.0 |
| Oct 06, 2026 | 11.12 | 11.25 | 10.64 | 10.68 | 954530.0 |
| Oct 05, 2026 | 10.94 | 11.20 | 10.70 | 11.05 | 1.206M |
| Oct 02, 2026 | 11.29 | 11.29 | 10.73 | 10.94 | 1.575M |
| Oct 01, 2026 | 11.39 | 11.67 | 11.03 | 11.07 | 953156.0 |
| Sep 30, 2026 | 11.69 | 11.93 | 11.32 | 11.47 | 1.411M |
| Sep 29, 2026 | 11.79 | 11.80 | 11.31 | 11.50 | 1.140M |
| Sep 28, 2026 | 11.57 | 11.93 | 11.39 | 11.74 | 811300.0 |
| Sep 25, 2026 | 11.89 | 11.92 | 11.53 | 11.66 | 1.533M |
| Sep 24, 2026 | 12.35 | 12.42 | 11.38 | 11.89 | 1.872M |
| Sep 23, 2026 | 14.29 | 14.39 | 12.06 | 12.52 | 2.142M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Korsana Biosciences, Inc. | 31.00 |
| Cullinan Therapeutics, Inc. | 15.31 |
| Q32 Bio, Inc. | 8.86 |
| Arrowhead Pharmaceuticals, Inc. | 59.26 |
| Oncolytics Biotech, Inc. | 0.4352 |
Price Related Metrics
| PEG Ratio | -0.6204 |
| Price to Book Value | 2.376 |
| Earnings Yield | -8.35% |
| Market Cap | 569.19M |
| PEGY Ratio | -0.6204 |